Cargando…
Development of Agranulocytosis after Discontinuation of Methimazole: An Unusual Case
Agranulocytosis is a rare and critical adverse effect of antithyroid drugs (ATD). The occurrence of agranulocytosis in continuous ATD treatment patients is well known; however, a case of ATD agranulocytosis occurring following the discontinuation of methimazole (MMI) treatment is not a usual situati...
Autores principales: | Üçler, Rıfkı, Atmaca, Murat, Candar, Ömer, Alay, Murat, Göy, Burhan, Kara, Erdal, Turan, Mahfuz, Demir, Yusuf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538967/ https://www.ncbi.nlm.nih.gov/pubmed/26339512 http://dx.doi.org/10.1155/2015/974524 |
Ejemplares similares
-
A Rare Presentation of Transfusional Hemochromatosis: Hypogonadotropic Hypogonadism
por: Ucler, Rifki, et al.
Publicado: (2015) -
Agranulocytosis with tonsillitis associated with methimazole therapy
por: Zambrana, Jorge T., et al.
Publicado: (2015) -
SAT-600 Relapse of Agranulocytosis after Recovery of Methimazole-Induced Agranulocytosis
por: Choi, Dughyun, et al.
Publicado: (2019) -
A patient with agranulocytosis following the discontinuation of methimazole treatment for 4 months: A case report
por: BAI, XIAO-SU, et al.
Publicado: (2014) -
Glycogenic Hepatopathy in Type 1 Diabetes Mellitus
por: Atmaca, Murat, et al.
Publicado: (2015)